Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients

Tigecycline is a broad-spectrum active intravenous antibiotic that is active against methicillin-resistant staphylococcus aureus. In Phase 3 and 4 clinical trials, increased all-cause mortality was observed in patients treated with tigecycline compared to patients in the control group. The reason fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li-Hua, Bai, Kun-Hao, Wu, Guo-Yan, Tian, Xiao-Peng, Zou, Zhi-Qing, Wang, Da-Wei, Dai, Yu-Jun, Chen, Si-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294380/
https://www.ncbi.nlm.nih.gov/pubmed/35865948
http://dx.doi.org/10.3389/fphar.2022.891952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294380/
https://www.ncbi.nlm.nih.gov/pubmed/35865948
http://dx.doi.org/10.3389/fphar.2022.891952

Ejemplares similares